Business Wire · TENX · November 3, 2026

Securities Fraud Class Action Filed Against Tenax Therapeutics, Inc.: Glancy Prongay Wolke & Rotter LLP Announces Lead Plaintiff Deadline

Get the app for more

Explore stock news, insights and company research.